Natasha Lomas

Artificial intelligence continues stirring things up in chemistry. To wit: Y Combinator-backed Cambridge, U.K.-based ReactWise is using AI to speed up chemical manufacturing — a key step in bringing new drugs to market. Once a promising drug has been identified in the lab, pharma firms need to be able to produce much larger amounts of the material to run clinical trials. This is where ReactWise is offering to step in with its “AI copilot for

Canadian biotech startup Afynia Laboratories, a spin-out from McMaster University in Ontario, has picked up $5 million in seed funding to commercialize a blood test for endometriosis — a medical condition that can afflict people with a uterus, causing problems like chronic pelvic pain and fertility issues. Endometriosis affects nearly 200 million people worldwide. Getting a diagnosis remains challenging, with some women reporting that it can take years — even up to a decade —